Todd Zavodnick
Chief Executive Officer presso Dermavant Sciences Ltd.
Profilo
Todd Zavodnick is currently the Chief Executive Officer at Dermavant Sciences, Inc. and the Chief Executive Officer & Director at Dermavant Sciences Ltd.
He is also a Director at Allurion Technologies, Inc. (Old) and the Children's Skin Disease Foundation.
Previously, he served as an Independent Director at NovaBay Pharmaceuticals, Inc. from 2016 to 2019.
He was also the Chief Commercial Officer at Revance Therapeutics, Inc. from 2017 to 2018 and the President-International at ZELTIQ Aesthetics, Inc. from 2016 to 2017.
Mr. Zavodnick held the position of President-China & Mongolia Region at Alcon Laboratories, Inc. from 1998 to 2012 and was the President & General Manager at Galderma Laboratories LP from 2012 to 2016.
He completed his undergraduate degree at Rutgers State University of New Jersey in 1994 and obtained an MBA from The University of Texas at Austin in 2006.
Posizioni attive di Todd Zavodnick
| Società | Posizione | Inizio |
|---|---|---|
| Children's Skin Disease Foundation | Director/Board Member | - |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The private company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Chief Executive Officer | 15/11/2018 |
Dermavant Sciences Ltd.
 Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Chief Executive Officer | 01/11/2018 |
Precedenti posizioni note di Todd Zavodnick
| Società | Posizione | Fine |
|---|---|---|
| NOVABAY PHARMACEUTICALS | Director/Board Member | 11/09/2019 |
| REVANCE THERAPEUTICS, INC. | Corporate Officer/Principal | 09/11/2018 |
| ZELTIQ AESTHETICS INC | Corporate Officer/Principal | 01/08/2017 |
Galderma Laboratories LP
 Galderma Laboratories LP Pharmaceuticals: MajorHealth Technology Galderma Laboratories LP develops and markets dermatology and prescription products. It also offers treatments for skin conditions such as acne, rosacea, atopic dermatitis, soriasis, melasma and sunspots. Galderma Laboratories was founded in 1961 and is headquartered in Fort Worth, TX. | President | 11/01/2016 |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Corporate Officer/Principal | 01/04/2012 |
Formazione di Todd Zavodnick
| Rutgers State University of New Jersey | Undergraduate Degree |
| The University of Texas at Austin | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| REVANCE THERAPEUTICS, INC. | Health Technology |
| NOVABAY PHARMACEUTICALS | Health Technology |
| Aziende private | 7 |
|---|---|
ZELTIQ Aesthetics, Inc.
 ZELTIQ Aesthetics, Inc. Medical SpecialtiesHealth Technology ZELTIQ Aesthetics, Inc. is a medical technology company, which focuses on developing and commercializing products. Its product, the coolsculpting system is designed to selectively reduce stubborn fat bulges. The company was founded by Mitchell E. Levinson in 2005 and is headquartered in North Chicago, IL. | Health Technology |
Allurion Technologies, Inc. (Old)
 Allurion Technologies, Inc. (Old) Internet Software/ServicesTechnology Services Allurion Technologies, Inc. develops a treatment for obesity. The firm offers a medical device for obesity that can be delivered and removed without surgery or endoscopy. The company was founded by Shantanu k. Gaur and Samuel G. Levy in 2009 and is headquartered in Natick, MA. | Technology Services |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Health Technology |
Galderma Laboratories LP
Galderma Laboratories LP Pharmaceuticals: MajorHealth Technology Galderma Laboratories LP develops and markets dermatology and prescription products. It also offers treatments for skin conditions such as acne, rosacea, atopic dermatitis, soriasis, melasma and sunspots. Galderma Laboratories was founded in 1961 and is headquartered in Fort Worth, TX. | Health Technology |
| Children's Skin Disease Foundation | |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The private company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Health Technology |
Dermavant Sciences Ltd.
Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Todd Zavodnick
